Adma Biologics (ADMA) FCF Margin (2011 - 2025)
Adma Biologics (ADMA) posted FCF Margin of 24.83% for Q4 2025, up 3200.34% on a QoQ basis from 0.8% in Q3 2025, and down 1554.0% year-over-year from 1.71% in Q4 2024.
Adma Biologics (ADMA) FCF Margin (2011 - 2025) Analysis & Trends
Adma Biologics' FCF Margin history runs 13 years deep, the most recent figure standing at 24.83% for Q4 2025.
- Quarterly FCF Margin fell 1554.0% year-over-year to 24.83% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 5.45% (down 2045.0% YoY) and the FY2025 annual result came in at 5.45%, down 2045.0% from the prior year.
- FCF Margin was 24.83% for Q4 2025 at Adma Biologics, up from 0.8% in the prior quarter.
- Across five years, FCF Margin topped out at 40.66% in Q2 2024 and bottomed at 223.07% in Q1 2021.
- A 5-year average of 32.71% and a median of 16.38% in 2023 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2021 — FCF Margin surged 18912 bps — and 2025, when it slumped 2531 bps.
- Adma Biologics' FCF Margin stood at 67.53% in 2021, then soared by 67 bps to 22.26% in 2022, then surged by 200 bps to 22.19% in 2023, then surged by 82 bps to 40.37% in 2024, then slumped by 38 bps to 24.83% in 2025.
- Business Quant data shows ADMA's FCF Margin at 24.83% in Q4 2025, 0.8% in Q3 2025, and 15.34% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn | 24.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.83% |
| Sep 30, 2025 | -0.80% |
| Jun 30, 2025 | 15.34% |
| Mar 31, 2025 | -21.23% |
| Dec 31, 2024 | 40.37% |
| Sep 30, 2024 | 20.00% |
| Jun 30, 2024 | 40.66% |
| Mar 31, 2024 | -5.58% |
| Dec 31, 2023 | 22.19% |
| Sep 30, 2023 | 10.21% |
| Jun 30, 2023 | -11.53% |
| Mar 31, 2023 | -29.29% |
| Dec 31, 2022 | -22.26% |
| Sep 30, 2022 | -40.56% |
| Jun 30, 2022 | -22.36% |
| Mar 31, 2022 | -99.15% |
| Dec 31, 2021 | -67.53% |
| Sep 30, 2021 | -78.34% |
| Jun 30, 2021 | -206.04% |
| Mar 31, 2021 | -223.07% |